Press release
Cancer Cachexia Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight
Discover Key Insights into the Cancer Cachexia Market with DelveInsight's In-Depth Report @ Cancer Cachexia Market Size [https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Cancer Cachexia Market Report
* According to the Cancer Cachexia Hub, approximately half of all patients with cancer experience cachexia. This rate of occurrence rises to as high as 86% in the last 1-2 weeks of life, with 45% of patients losing more than 10% of their original body weight over disease progression.
* Several secondary studies suggest that the overall incidence of cachexia is high and in industrialized countries, such as North America, Europe, and Japan it is growing. It is currently estimated that cachexia affects approximately 9 million patients, which is about 1% of all patients with any disease.
* As per a Japanese study conducted by Aoyagi et al. "Cancer cachexia, mechanism and treatment", cachexia occurs in the majority of terminal cancer patients and is responsible for the death of 22% of cancer patients.
* According to Worp et al. (2020), approximately 70% of gastric cancer patients, 80% of lung cancer patients, and 90% of liver and pancreatic cancer patients are at risk of developing cachexia.
* It is estimated that more than 30% of cancer patients die due to cachexia, and more than 50% of patients die with cachexia being present.
* Among late-stage patients, cachexia affects 50-80% of cancer patients.
* The leading Cancer Cachexia Companies such as AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech , and others.
* Promising Cancer Cachexia Therapies such as SAT-003, ponsegromab, Pancrelipase, Anamorelin Hydrochloride , and others.
Stay ahead in the Cancer Cachexia Therapeutics Market with DelveInsight's Strategic Report @ Cancer Cachexia Market Outlook [https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Cancer Cachexia Epidemiology Segmented in the 7MM
* Total Incident cases of Selected Cancer indications for Cancer Cachexia
* Prevalent Cases of Cancer Cachexia
* Treatable cases of Cancer Cachexia
Download the report to understand which factors are driving Cancer Cachexia epidemiology trends @ Cancer Cachexia Prevalence [https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Cancer Cachexia Drugs Market
As per DelveInsight, the dynamics of the cancer cachexia market are anticipated to change in the coming years owing to the positive outcomes of some of the rare candidates during the developmental stage by key players, such as Actimed Therapeutics (ACM-001), Aveo Oncology (AV-380), Pfizer (PF 06946860), Extend Biosciences (EXT418) and others that are under early phase of clinical development.
Cancer Cachexia Companies
AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech, are among others major key players in the Cancer Cachexia therapeutics market. The launch of emerging therapies is expected to create a significant positive shift in the cancer cachexia market size and treatment outlook.
Get In-Depth Knowledge on Cancer Cachexia Market Trends and Forecasts with DelveInsight @ Cancer Cachexia Treatment Market [https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Cancer Cachexia Market Report
* Coverage- 7MM
* Cancer Cachexia Companies- AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech, and others.
* Cancer Cachexia Therapies- SAT-003, ponsegromab, Pancrelipase, Anamorelin Hydrochloride, and others.
* Cancer Cachexia Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Cancer Cachexia Unmet Needs, KOL's views, Analyst's views, Cancer Cachexia Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight's Comprehensive Cancer Cachexia Market Report @ Cancer Cachexia Market Drivers and Barriers [https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Executive Summary of Cancer Cachexia (CC)
3. Competitive Intelligence Analysis for Cancer Cachexia (CC)
4. Cancer Cachexia (CC): Market Overview at a Glance
5. Cancer Cachexia (CC): Disease Background and Overview
6. Cancer Cachexia Patient Journey
7. Cancer Cachexia (CC) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Cancer Cachexia Unmet Needs
10. Key Endpoints of Cancer Cachexia Treatment
11. Cancer Cachexia Marketed Products
12. Cancer Cachexia Emerging Therapies
13. Cancer Cachexia (CC): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Cancer Cachexia (CC)
17. KOL Views
18. Cancer Cachexia Market Drivers
19. Cancer Cachexia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cancer-cachexia-market-size-in-the-7mm-is-expected-to-grow-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/in-licensing-opportunity
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Cachexia Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight here
News-ID: 3755273 • Views: …
More Releases from ABNewswire
Active Implantable Medical Devices Market Is Expected to Reach USD 44,906.36 mil …
The leading companies operating in the active implantable medical devices market include Medtronic, Johnson and Johnson Services, Inc., Abbott, Boston Scientific Corporation, LivaNova PLC., Axonics, Inc., Aleva Neurotherapeutics, Sonova Holding AG, Bioventus Inc., CARMAT, Jarvik Heart Inc., BIOTRONIK SE & Co. KG, MicroTransponder Inc., MED-EL Medical Electronics, NeuroPace, Inc., NEVRO CORP., Shree Pacetronix, Cochlear Ltd., Berlin Heart, Blackrock Neurotech, and others.
DelveInsight's "Active Implantable Medical Devices Market Insights, Competitive Landscape, and…
Global Heparin Market Poised to Reach USD 18.19 Billion by 2032, Driven by Risin …
Major players shaping the global heparin market include Pfizer Inc., Dr. Reddy's Laboratories Ltd., Gland Pharma Limited, Sanofi, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Novartis AG, Baxter, Leo Pharma A/S, and Cardinal Health. Continuous investments in R&D, formulation improvements, mergers, and global distribution partnerships remain vital elements of their growth strategy.
DelveInsight's "Heparin Market Insights, Competitive Landscape, and Market Forecast - 2032" report delivers a comprehensive analysis of…
Global Phage Therapy Pipeline Accelerates as 20+ Biotech Companies Advance Next- …
Key phage therapy companies such as Locus Biosciences, Armata Pharmaceuticals, BiomX, SNIPR Biome, Phagelux, PHAXIAM Therapeutics, Phico Therapeutics, Technophage, and others.
DelveInsight's 'Phage Therapies Competitive Landscape 2025' report provides comprehensive global coverage of pipeline phage therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the phage therapies pipeline domain.
The phage therapy market is witnessing robust growth driven by…
Systemic Juvenile Idiopathic Arthritis Market Analysis 2034 - Competitive Landsc …
Systemic Juvenile Idiopathic Arthritis Companies are Chugai Pharmaceutical, AstraZeneca, Pfizer, Incyte Corporation Novartis, Roche, Genentech, AbbVie, Pfizer, Eli Lilly and Company, Bristol Myers Squibb, Johnson & Johnson, Merck & Co., UCB, Sanofi, and others.
DelveInsight's "Systemic Juvenile Idiopathic Arthritis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Systemic Juvenile Idiopathic Arthritis, historical and forecasted epidemiology as well as the Systemic Juvenile Idiopathic Arthritis market trends in the…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
